BSAC vs. IBN: Which Stock Is the Better Value Option?
Yahoo Finance · 2 weeks ago
Open | 28.40 |
High | 28.59 |
Low | 28.30 |
Mkt Cap | 102.66B |
P/E (TTM) | 19.31 |
Div & Yield | 0.19 & 0.68% |
Prev. Close | 28.62 |
52 Wk. Low | 21.89 |
52 Wk. High | 29.66 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 460.6B | 77.60% ▲ |
Net Income | 116.72B | 18.50% ▲ |
Diluted EPS | 0.39 | 18.50% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.34 | - |
Q1 2024 | $0.32 | $0.39 |
Q4 2023 | $0.35 | $0.37 |
S&P 500^GSPC | 5,472.57+45.44 (+0.84%) |
Dow 30^DJI | 40,326.70+472.83 (+1.19%) |
Nasdaq^IXIC | 17,467.83+125.42 (+0.72%) |
115.35+0.96% | |
11.38-16.75% | |
AbbVie Inc.ABBV | 183.35+4.05% |